Related Experiment Video

Updated: Jun 16, 2025

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

22.5K

LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting

Yulan Xiong1, Jianzhong Yu2

  • 1Department of Neuroscience, University of Connecticut School of Medicine, Farmington, CT 06030, USA.

Trends in Molecular Medicine
|August 17, 2024
PubMed

Insights

Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of Parkinson's disease (PD). This review explores LRRK2's upstream regulation, downstream effects, and therapeutic strategies for PD.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Leucine-rich repeat kinase 2 (LRRK2) mutations are the leading genetic cause of Parkinson's disease (PD).
  • Altered LRRK2 enzymatic activity and protein levels are implicated in PD pathogenesis.
  • Understanding LRRK2 regulation is key to deciphering PD mechanisms.

Purpose of the Study:

  • To review the upstream regulatory mechanisms of LRRK2.
  • To discuss the downstream substrates and cellular consequences of LRRK2 dysregulation.
  • To explore therapeutic strategies and clinical trial challenges for LRRK2-targeted treatments in PD.

Main Methods:

  • Literature review focusing on LRRK2 upstream regulation.
  • Discussion of LRRK2 downstream targets and cellular effects.
  • Analysis of current and future therapeutic approaches for LRRK2 in Parkinson's disease.

Main Results:

  • LRRK2 activation pathways and their link to PD.
  • Identification of key downstream effectors and cellular processes influenced by LRRK2.
  • Overview of therapeutic interventions and associated clinical trial hurdles.

Conclusions:

  • Deciphering LRRK2 regulation is critical for understanding Parkinson's disease.
  • Targeting LRRK2 presents promising therapeutic avenues but faces significant challenges.
  • Further research is needed to address outstanding questions in the LRRK2 field.
Keywords:
LRRK2Parkinson's diseasedisease mechanismsleucine-rich repeat kinase 2therapeutic targetsupstream regulation

More Related Videos

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation12:49

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

7.5K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

15.0K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
240
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
501
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K